Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ningbo Changhong Polymer Scientific and Technical Inc. (605008.SS)
Ningbo, CN
Ningbo Changhong Polymer Scientific and Technical Inc. is a Chinese manufacturer specializing in the production of advanced styrene-butadiene-styrene (SBS) and styrene-ethylene-butadiene-styrene (SEBS) polymers. These versatile polymers find extensive application across numerous industrial sectors; they are integral components in everything from footwear manufacturing and construction materials (including waterproofing solutions) to asphalt and plastic modification. Furthermore, their uses extend to adhesive agents, pharmaceutical and health products, as well as specialized applications in plastic runways and bicycle tires. Established in 2012, the company maintains its operational base in Ningbo, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.29% | +0.08% | +0.08% | -6.94% | -29.42% | -14.44% | -28.80% | -16.37% | -35.36% | +12.64% | +12.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+8.0% ★ Q1'26: +11.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-106.7% Q1'26: -33.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-10.9% Q1'26: -15.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+2.1% Q1'26: -0.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.1% Q1'26: -0.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+27.1% Q1'26: +31.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×7.62× Q1'26: -403.40× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.30B
est: 1.31B (-1.0%)
|
1.73B
est: 2.09B (-17.1%)
|
2.37B
est: 3.13B (-24.2%)
|
1.42B
est: 2.43B (-41.8%)
|
3.63B
est: 3.14B (+15.7%)
|
3.92B
est: 3.83B (+2.4%)
|
4.55B
4.55B – 4.55B
+18.8% YoY
|
5.48B
5.48B – 5.48B
+20.5% YoY
|
| EBITDA |
432.82M
est: 219.44M (+97.2%)
|
303.32M
est: 350.26M (-13.4%)
|
375.41M
est: 524.14M (-28.4%)
|
298.63M
est: 407.21M (-26.7%)
|
334.49M
est: 445.96M (-25.0%)
|
289.88M
est: 544.09M (-46.7%)
|
646.21M
646.21M – 646.21M
+18.8% YoY
|
778.43M
778.43M – 778.43M
+20.5% YoY
|
| EBIT |
363.96M
est: 143.46M (+153.7%)
|
229.41M
est: 228.98M (+0.2%)
|
245.88M
est: 342.66M (-28.2%)
|
162.89M
est: 266.22M (-38.8%)
|
175.35M
est: 263.82M (-33.5%)
|
81.52M
est: 321.87M (-74.7%)
|
382.28M
382.28M – 382.28M
+18.8% YoY
|
460.50M
460.50M – 460.50M
+20.5% YoY
|
| Net Income |
301.63M
est: 303.01M (-0.5%)
|
184.98M
est: 334.23M (-44.7%)
|
180.46M
est: 507.77M (-64.5%)
|
95.01M
est: 231.39M (-58.9%)
|
94.22M
est: 231.58M (-59.3%)
|
-7.99M
est: 199.64M (-104.0%)
|
271.51M
271.51M – 271.51M
+36.0% YoY
|
423.23M
423.23M – 423.23M
+55.9% YoY
|
| SGA |
30.80M
est: 34.60M (-11.0%)
|
55.74M
est: 55.22M (+0.9%)
|
48.13M
est: 82.63M (-41.8%)
|
55.04M
est: 64.20M (-14.3%)
|
61.70M
est: 72.03M (-14.3%)
|
25.05M
est: 87.88M (-71.5%)
|
104.37M
104.37M – 104.37M
+18.8% YoY
|
125.73M
125.73M – 125.73M
+20.5% YoY
|
| EPS |
0.49
est: 0.47 (+3.9%)
|
0.29
est: 0.52 (-44.2%)
|
0.28
est: 0.79 (-64.6%)
|
0.15
est: 0.36 (-58.3%)
|
0.15
est: 0.29 (-48.3%)
|
-0.01
est: 0.25 (-104.0%)
|
0.34
0.34 – 0.34
+36.0% YoY
|
0.53
0.53 – 0.53
+55.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 49.4K | 0.29% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 27.2K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hua Bai | Deputy GM, Secretary of the Board of Directors & Director | — | male |
| Liang Ma | Accounting Supervisor | — | — |
| Long Shuang Hu | Financial Director | — | male |
| Xiangdong Zhang | Deputy General Manager | — | male |
| Zhengbo Wang | General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 605008.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
